License Grant. Subject to the limitations and other terms and conditions set forth in this Agreement including those reserved by Institute in [Section 2.5(a)], Institute hereby grants to Licensee an exclusive, royalty-bearing, sublicenseable (in accordance with [Article 3]) license in, to and under # the Patent Rights and the Know-How Rights, and # Institute’s interest in any patents and patent applications owned jointly by Licensee and Institute, to make, use, Sell, offer for Sale and import Licensed Products, and to practice Licensed Methods, in each case with respect to # Allogeneic CTL Products in the Territory in the Licensed Field, # solely with respect to HPV-Specific CTL Products, EBV-Specific Autologous Products, and Autologous CTL Products in the Licensed Field, and # solely following ​ arising from the ​.

License Grant. Subject to the terms and conditions of this Agreement, Licensor hereby grants to Company an exclusive (even as to Licensor, subject to any Definitive Agreement, if applicable), worldwide, fully paid-up, royalty-free license, with the right to sublicense through multiple tiers of sublicense, under the Licensed Technology, to research, develop, make, have made, use, sell, offer for sale, have sold and import any Product in the Field. For the avoidance of doubt, subject to the terms and conditions of this Agreement, Company shall be free to use, disclose, reproduce, license, and otherwise distribute and exploit the Licensed Technology with respect to any Product in the Field as it sees fit, without any obligation or duty to account to Licensor.

License Grant. Subject to the reservations of rights set forth in Paragraph 2.2, BCM hereby grants to LICENSEE an exclusive, worldwide, sublicensable license under the Patent Rights and Subject Technology, to make, have made, use, market, sell, offer to sell, lease and import Licensed Products in the Field.

License Grant. As of the Effective Date, Novo shall grant to TransTech an exclusive (even as to Novo), royalty-bearing license, under the Novo Intellectual Property, to discover, Develop, Manufacture, have Manufactured, use and Commercialize in the Field in the Territory Licensed Products.

License Grant. Urovant hereby grants to Sunovion during the Term a non-exclusive license, with the right to grant sublicenses, under any intellectual property rights owned or controlled by Urovant in the Territory, including with respect to the Materials, Work Product and IP solely to enable Sunovion to perform the Co-Promotion Activities.

License Grant. Subject to the terms and conditions of this Agreement, including Merck’s retained rights under [Section 2.3], Merck hereby grants to Licensee an exclusive (even as to Merck), sub-licensable (subject to the obligations and restrictions in [Section 2.5]), royalty-bearing license under the Merck Know-How, Compound Patent Rights, and Merck’s interest in any solely or jointly owned Program IP to Develop, make, have made, use, import, export, Commercialize, sell, offer for sale, and market the Licensed Compound and Licensed Product in the Field in the Territory.

License Grant. Subject to the terms and conditions of this Agreement, [[Aravive:Organization]] hereby grants [[3D Medicines:Organization]] an exclusive (even as to [[Aravive:Organization]] except as provided in Section 2.1(b) below) license, with the right to sublicense (solely as provided in Section 2.1(c)), under the [[Aravive:Organization]] Technology, to Develop, Manufacture and have Manufactured (solely in accordance with Section 7.2), distribute, market, promote, sell, have sold, offer for sale, import, label, package and otherwise Commercialize Licensed Products in the Field in the [[3D Medicines:Organization]] Territory. For clarity, no rights shall be granted to [[3D Medicines:Organization]] under this Section 2.1(a), with respect to the Development, Manufacture or Commercialization of any product containing the Licensed Compound together with one or more Drug Substances other than the Licensed Compound or use in combination with one or more Drug Substances other than the Licensed Compound. As consideration for the foregoing license and access to and transfers of know-how under this Agreement, [[3D Medicines:Organization]] will make certain payments to [[Aravive:Organization]] as set out in, and subject to the terms and conditions of, Article 8.

License Grant. Subject to the reservations of rights set forth in Paragraph 2.2, BCM hereby grants to LICENSEE an exclusive, worldwide, sublicensable license under the Patent Rights and Subject Technology, to make, have made, use, market, sell, offer to sell, lease and import Licensed Products in the Field.

License Grant. Subject to the terms and conditions of this Agreement, including Merck’s retained rights under [Section 2.3], Merck hereby grants to Licensee an exclusive (even as to Merck), sub-licensable (subject to the obligations and restrictions in [Section 2.5]), royalty-bearing license under the Merck Know-How, Compound Patent Rights, and Merck’s interest in any solely or jointly owned Program IP to Develop, make, have made, use, import, export, Commercialize, sell, offer for sale, and market the Licensed Compound and Licensed Product in the Field in the Territory.

License Grant. Subject to the terms and conditions of this Agreement, Puma hereby grants to Pint an exclusive, sublicensable (subject to Section 3.3), royalty-bearing license, under Puma’s interest in the Puma IP, # to Use the Product in the Territory and # to Manufacture or have Manufactured Product anywhere in the world, solely for Use in the Territory, such license to Manufacture only to be exercisable when and as provided in the Supply Agreement.